KHLMVGHM
AZN icon

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s AstraZeneca AZN Stock Holding History

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-76,310
Closed -$9.99M – 64
2024
Q4 		$9.99M Buy
+76,310
New +$10.7M 0.79% 42

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's AZN Position: Q1 2025 in Review

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold out of AstraZeneca (AZN) in Q1 2025, closing a stake of 76,310 shares — an estimated $9.99M sold.

Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in AZN in Q4 2024 and held it in 1 quarter. The position peaked at $9.99M in Q4 2024. 1,250 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet sold 76,310 AstraZeneca shares in Q1 2025, an estimated $9.99M.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet first reported a position in AstraZeneca in Q4 2024 and held it in 1 quarter.
  • Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's AstraZeneca position peaked at $9.99M in Q4 2024.
  • 1,250 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet's 13F filing for Q1 2025, filed 7 May 2025.